Is there a functional correlate of Kv1.5 in the ventricle of canine heart and what would it mean for the use of I(Kur) blockers?
- PMID: 17876301
- PMCID: PMC2078221
- DOI: 10.1038/sj.bjp.0707463
Is there a functional correlate of Kv1.5 in the ventricle of canine heart and what would it mean for the use of I(Kur) blockers?
Abstract
The cardiac ultrarapid outward current I(Kur), encoded by KCNA5, is of special pharmacological interest, because it is considered to be atrium-specific. I(Kur) has therefore become a target in the therapy of atrial tachyarrhythmias. However, the concept of atrium specificity is only valid if a functional I(Kur) current is in fact absent from the ventricle. However, new work has detected a I(Kur)-like current in canine ventricular myocytes, sensitive to 4-aminopyridine and suppressed by the I(Kur) blocker DPO-1, findings that support the existence of a functional ventricular I(Kur). These indications are, however, indirect and more effort is needed to clarify unequivocally the putative role of an expectedly small I(Kur) component in the ventricle.
Comment on
-
The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization.Br J Pharmacol. 2007 Nov;152(6):870-9. doi: 10.1038/sj.bjp.0707403. Epub 2007 Aug 13. Br J Pharmacol. 2007. PMID: 17700726 Free PMC article.
Similar articles
-
Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):482-7. doi: 10.1007/s00210-002-0599-x. Epub 2002 Sep 5. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 12382079
-
In vivo cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker, (2-Isopropyl-5-methylcyclohexyl) diphenylphosphine oxide, in rat and nonhuman primate.J Pharmacol Exp Ther. 2006 Feb;316(2):727-32. doi: 10.1124/jpet.105.094839. Epub 2005 Oct 21. J Pharmacol Exp Ther. 2006. PMID: 16243963
-
The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization.Br J Pharmacol. 2007 Nov;152(6):870-9. doi: 10.1038/sj.bjp.0707403. Epub 2007 Aug 13. Br J Pharmacol. 2007. PMID: 17700726 Free PMC article.
-
Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.Cardiovasc Res. 2011 Mar 1;89(4):776-85. doi: 10.1093/cvr/cvq398. Epub 2010 Dec 15. Cardiovasc Res. 2011. PMID: 21159668 Review.
-
I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillation.Expert Opin Investig Drugs. 2009 Apr;18(4):399-416. doi: 10.1517/13543780902762850. Expert Opin Investig Drugs. 2009. PMID: 19335273 Review.
Cited by
-
Polyunsaturated Fatty acids modify the gating of kv channels.Front Pharmacol. 2012 Sep 10;3:163. doi: 10.3389/fphar.2012.00163. eCollection 2012. Front Pharmacol. 2012. PMID: 22973228 Free PMC article.
-
The Pattern of mRNA Expression Is Changed in Sinoatrial Node from Goto-Kakizaki Type 2 Diabetic Rat Heart.J Diabetes Res. 2018 Sep 2;2018:8454078. doi: 10.1155/2018/8454078. eCollection 2018. J Diabetes Res. 2018. PMID: 30246030 Free PMC article.
-
Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure.Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar;379(3):225-32. doi: 10.1007/s00210-008-0361-0. Epub 2008 Oct 30. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 18972103
References
-
- Blaauw Y, Gögelein H, Tieleman RG, Van Hunnik A, Schotten U, Allessie MA. ‘Early' class III drugs for the treatment of atrial fibrillation. Efficacy and atrial selectivity of AVE0118 in remodelled atria of the goat. Circulation. 2004;110:1717–1724. - PubMed
-
- Ehrlich JR, Nattel S, Hohnloser SH. Novel anti-arrhythmic drugs for atrial fibrillation management. Curr Vasc Pharmacol. 2007;5:185–195. - PubMed
-
- Fedida D, Eldstrom J, Hesketh JC, Lamorgese M, Castel L, Steele DF, et al. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes. Circ Res. 2003;93:744–751. - PubMed
-
- Feng J, Wible B, Li GR, Wang Z, Nattel S. Antisense oligonucleotides directed aginst Kv1-5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. Circ Res. 1997;80:572–579. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources